BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15771798)

  • 21. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
    Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
    Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic ultrasound with radiofrequency ablation in cirrhotic patients with hepatocellular carcinoma: technique and technical considerations.
    Podnos YD; Henry G; Ortiz JA; Ji P; Cooke J; Cao S; Imagawa DK
    Am Surg; 2001 Dec; 67(12):1181-4. PubMed ID: 11768826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laparoscopic and percutaneous ultrasound guided radiofrequency ablation for hepatocellular carcinoma: a preliminary study].
    Jung MK; Lee JH; Kim TS; Kim HS; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Chung JM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):209-17. PubMed ID: 12499807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [First reported case of lung metastasis from hepatocellular carcinoma successfully treated by ultrasound-guided radiofrequency ablation using ultrasonic contrast agent].
    Hachisuka Y; Uomoto M; Fujisawa T; Mogami H
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2657-9. PubMed ID: 20009475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels.
    Thanos L; Mylona S; Galani P; Pomoni M; Pomoni A; Koskinas I
    Diagn Interv Radiol; 2008 Mar; 14(1):51-6. PubMed ID: 18306146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma.
    Nouso K; Shiraga K; Uematsu S; Okamoto R; Harada R; Takayama S; Kawai W; Kimura S; Ueki T; Okano N; Nakagawa M; Mizuno M; Araki Y; Shiratori Y
    Liver Int; 2005 Oct; 25(5):967-72. PubMed ID: 16162154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas.
    Qu JR; Liu CC; Zhang HK; Li X; Zhang JW; Luo JP; Shao NN; Zhang SN; Li YL; Li HL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):480-5. PubMed ID: 23134824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application value of real-time three-dimensional contrast-enhanced ultrasound for morphological assessing of hepatocellular carcinoma before radiofrequency ablation treatment].
    Wang XC; Li SY; Fang Y; Zhou L; Xu LL; Wu Y
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):217-221. PubMed ID: 29575843
    [No Abstract]   [Full Text] [Related]  

  • 31. Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence?
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Okabe S; Kanai F; Yoshikawa M; Yokosuka O
    Ultrasound Med Biol; 2012 Nov; 38(11):1902-10. PubMed ID: 23026230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
    Rhim H; Lim HK; Kim YS; Choi D
    AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultrasound-guided assistant infusion technique for percutaneous radiofrequency ablation of liver cancer].
    Han Y; Hao YZ; Cai JQ; Yang M; Liu S; He LF; Yu L; Chen MH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):266-9. PubMed ID: 22964146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High mechanical index post-contrast ultrasonography improves tissue structural display of hepatocellular carcinoma.
    Chen MH; Yang W; Dai Y; Wu W
    Chin Med J (Engl); 2005 Dec; 118(24):2046-51. PubMed ID: 16438901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of hepatocellular carcinoma (HCC) treated with radiofrequency ablation (RFA) using 4D real-time ultrasound system.
    Hotta N; Fukuzawa Y; Ayada M; Sato K; Maeno T; Tagaya T; Okumura A; Ishikawa T; Ito Y; Kakumu S
    Hepatogastroenterology; 2005; 52(64):1224-7. PubMed ID: 16001667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unenhanced magnetic resonance imaging immediately after radiofrequency ablation of liver malignancy: preliminary results.
    D'Onofrio M; Cardobi N; Ruzzenente A; Conci S; Ciaravino V; Guglielmi A; Mucelli RP
    Abdom Radiol (NY); 2018 Jun; 43(6):1379-1385. PubMed ID: 28861631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results.
    Vallone P; Gallipoli A; Izzo F; Fiore F; Delrio P
    Anticancer Res; 2003; 23(6D):5075-9. PubMed ID: 14981969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Flexible applicator systems for radiofrequency ablation (RFA) of hepatic tumors].
    Gebauer B; Gaffke G; Hünerbein M; Felix R; Stroszczynski C
    Rofo; 2003 Dec; 175(12):1720-3. PubMed ID: 14661145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.
    Morimoto M; Sugimori K; Shirato K; Kokawa A; Tomita N; Saito T; Tanaka N; Nozawa A; Hara M; Sekihara H; Shimada H; Imada T; Tanaka K
    Hepatology; 2002 Jun; 35(6):1467-75. PubMed ID: 12029632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.